|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Institut für Physiologie, Universität Regensburg, Regensburg, Germany (J.O., R.S., S.P., R.S., K.K.); Department of Chemistry and Biochemistry, Faculty of Sciences, University of Lisboa and Centre of Human Genetics, National Institute of Health Dr. Ricardo Jorge, Lisboa, Portugal (M.S., A.R., A.S., T.G., M.D.A.); and Department of Physiology, Prince of Songkla University, Hat-Yai, Thailand (C.J.)
Received for publication April 4, 2006.
Accepted for publication October 25, 2006.
| Abstract |
|---|
|
|
|---|
|
| Materials and Methods |
|---|
|
|
|---|
Ussing Chamber Recordings. Tracheas were removed from normal mice (C57BL/6; Charles River Laboratories, Sulzfeld, Germany; animal facility University of Queensland) and mice homozygous for Phe508del-CFTR mice (Prof. Dr. B. Scholte, Institute of Cell Biology and Genetics, The Erasmus University Rotterdam, The Netherlands) after sacrificing the animals by cervical dislocation. After removing connective tissues, tracheas were opened by a longitudinal cut. Tissues were put immediately into an ice-cold buffer solution of the following composition: 145 mM NaCl, 3.8 mM KCl, 5 mM D-glucose, 1 mM MgCl2, 5 mM HEPES, and 1.3 mM calcium gluconate. The tissues were mounted into a perfused micro Ussing chamber with a circular aperture of 0.95 mm2. Apical and basolateral surfaces of the epithelium were perfused continuously at a rate of 5 to 10 ml/min (chamber volume 2 ml). The bath solution contained 145 mM NaCl, 0.4 mM KH2PO4, 1.6 mM K2HPO4, 5 mM D-glucose, 1 mM MgCl2, and 5 mM HEPES, and 1.3 mM calcium gluconate. pH was adjusted to 7.4, and all experiments were carried out at 37°C under open circuit conditions. Transepithelial resistance (Rte) was determined by applying short (1-s) current pulses (I = 0.5 µA) and the corresponding changes in transepithelial voltage (Vte) and basal Vte were recorded continuously. Values for Vte were referred to the serosal side of the epithelium. The equivalent short-circuit current (Isc) was calculated according to Ohm's law from Vte and Rte (Isc = Vte/Rte).
Cell Culture. Human bronchial epithelial cells (16HBE14o-) and human CF airway epithelial cells homozygous for Phe508del-CFTR (CFBE) were kindly provided by Prof. Dr. D.C. Gruenert (California Pacific Medical Center Research Institute, San Francisco, CA) and were grown at 37°C in DMEM containing 4 mM D-glucose, 2 mM L-glutamine, 100 g/l fetal calf serum, 100 mg/l penicillin/streptomycin in an atmosphere of 5% CO2 and 95% O2. Transfected baby hamster kidney (BHK) cells were grown in the presence of 500 µM methotrexate.
Patch-Clamp. Cells were mounted on the stage of an inverted microscope (IM35; Zeiss, Oberkochen, Germany) and kept at 37°C. The bath was continuously perfused with Ringer's solution at a rate of 5 to 10 ml/min. Patch-clamp experiments were performed in fast whole-cell configuration. The patch pipettes had an input resistance of 2-4M
when filled with a solution containing 30 mM KCl, 95 mM potassium gluconate, 1.2 mM NaH2PO4, 4.8 mM Na2HPO4, 1 mM EGTA, 0.726 mM CaCl2, 1.034 mM MgCl2, 5 mM D-glucose 5, and 1 mM ATP (32 mM Cl). The pH was adjusted to 7.2, and the Ca2+ activity was 0.1 µM. The access conductance was monitored continuously and was larger than 50 nS. Currents (voltage-clamp) and voltages (current-clamp) were recorded using a patch-clamp amplifier (EPC 7; List Medical Electronic, Darmstadt, Germany). Data were continuously stored on a computer hard disc. At regular intervals, membrane voltages were clamped in steps of 10 mV from -100 to +40 mV. Conductances were calculated according to Ohm's law.
Intracellular Ca2+ Concentration. For measurements of the intracellular Ca2+ concentration, cells were perfused with Ringer solution (145 mM NaCl, 0.4 mM KH2PO4, 1.6 mM K2HPO4, 5 mM glucose, 1 mM MgCl2, 1.3 mM Ca2+-gluconate) at 37°C. Cells were loaded with 5 µM Fura-2 AM (Invitrogen, Carlsbad, CA) in Opti-MEM (Invitrogen) with 0.02% Pluronic (Invitrogen) for 1 h at room temperature. Fura-2 was excited at 340/380 nm, and emission was recorded between 470 and 550 nm using a charge-coupled device camera (CoolSnap HQ; Visitron Systems, Puchheim, Germany). Fluorescence was measured continuously using an inverted microscope IMT-2 (Olympus Deutschland GmbH, Hamburg, Germany) and a high speed polychromator system (VisiChrome; Visitron Systems). Experiments were controlled and analyzed using the software package Meta-Fluor (Molecular Devices, Sunnyvale, CA). All optical filters and dichroic mirrors were from AHF (Tübingen, Germany).
cRNAs for CFTR, ENaC Subunits, and P2Y2. cDNAs encoding rat
,
,
ENaC (kindly provided by Prof. Dr. B. Rossier, Pharmacological Institute of Lausanne, Switzerland), wt-CFTR, Phe508del-CFTR, and the purinergic P2Y2 receptor were linearized in pBluescript with NotI or MluI and in vitro-transcribed using T7, T3, or SP6 promotor and polymerase (Promega, Madison, WI). After isolation from adult female Xenopus laevis frogs (Xenopus Express, Capetown, South Africa), oocytes were dispersed and defolliculated by a 45-min treatment with collagenase (type A; Roche, Mannheim, Germany). Subsequently, oocytes were rinsed and kept at 18°C in ND96 buffer (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM HEPES, and 2.5 mM sodium pyruvate, pH 7.55), supplemented with theophylline (0.5 mM) and gentamicin (5 mg/l).
Double Electrode Voltage-Clamp. Oocytes were injected with cRNA (1-10 ng) after dissolving in 47 nl of double-distilled water (Nanoliter Injector World Precision Instruments, Inc., Berlin, Germany). Water-injected oocytes served as controls. Two to 4 days after injection, oocytes were impaled with two electrodes (Harvard Bioscience, Edenbridge, UK) that had a resistance of <1M
when filled with 2.7 M KCl. Using two bath electrodes and a virtual-ground head stage, the voltage drop across Rserial was effectively zero. Membrane currents were measured by voltage-clamping of the oocytes (oocyte clamp amplifier; Warner Instruments, Hamden, CT) in intervals from -90 to +30 mV, in steps of 10 mV, each 1 s. Amiloride-sensitive conductances (GAmil) were used in the present report to express the amount of whole-cell conductance that is inhibited by 10 µM amiloride. During the whole experiment, the bath was continuously perfused at a rate of 5 to 10 ml/min. All experiments were conducted at room temperature (22°C).
Viability Assay and Western blot. Twenty-four hours after seeding BHK cells, culture medium was changed, methotrexate was removed, and Phyllanthus extract was added. Forty-eight hours later, cells were collected, washed once with phosphate-buffered saline, re-suspended in bovine serum albumin solution (0.5 mg/ml in phosphate-buffered saline) and stained with calcein AM and ethidium homodimer-1 (LIVE/DEAD Viability/Cytotoxicity Kit; Invitrogen). Membrane-permeant calcein-AM (excitation/emission, 494/517 nm) is cleaved by esterases in living cells to yield cytoplasmic green fluorescence, whereas membrane-impermeant ethidium homodimer-1 (excitation/emission, 528/617 nm) labels nucleic acids of membrane-compromised cells with red fluorescence. Flow cytometry analysis was carried out at excitation of 488 nm in a FACScalibur flow cytometer, (BD Biosciences, San Jose, CA). For Western blot, cells were lysed after treatment, and 30 to 50 µg of total protein was separated by SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose filters. Filters were probed with the anti-CFTR monoclonal antibody M3A7 (Chemicon, Temecula, CA).
Pulse-Chase and Immunoprecipitation Experiments. After treatment, cells were starved for 30 min in methionine-free DMEM (Invitrogen). Cells were then pulse-labeled for 30 min in the same medium with 150 µCi/ml [35S]methionine (MP Biomedicals, Irvine, CA) as described previously (Farinha and Amaral, 2005
). After chasing for 0, 0.5, 1, 2, and 3 h in DMEM supplemented with fetal bovine serum (Invitrogen) and 1 mM nonradioactive methionine, cells were lysed in 1 ml of radioimmunoprecipitation assay buffer and immunoprecipitated. In brief, samples were centrifuged at 14,000g for 30 min, and the supernatant was incubated overnight at 4°C with 1.5 µg of anti-CFTR M3A7 antibodies. Then, 25 µg of Protein-G agarose beads (Roche, Basel, Switzerland) were added for a further4hat 4°C; beads were washed four times using 1 ml of radioimmunoprecipitation assay buffer, and protein was eluted for 1 h at room temperature after addition of 80 µl of cracking buffer: 0.5 mM dithiothreitol (Sigma), 0.001% (w/v) bromphenol blue (Merck, Darmstadt, Germany), 5% (v/v) glycerol (Merck), 1.5% (w/v) SDS, and 31.25 mM Tris, pH 6.8. Samples were electrophoretically separated on 7% (w/v) polyacrylamide gels. Quantification of the core-glycosylated form of wt- or Phe508del-CFTR (band B) at a given chase time t was estimated as the percentage given by the ratio of the amount of the band B at that chase time (P) over its amount at chase time 0 (P0) (i.e., at the end of the pulse period). Likewise, maturation efficiency was determined by the appearance of the fully glycosylated form (band C) also as a percentage given by the ratio of P, the amount of band C at time t, over P0, the amount of band B at the start of the chase (t = 0).
Iodide Efflux Assay. Iodide efflux experiments were performed by a standard protocol using an ion-selective electrode. In brief, cells were incubated for 1 h in loading buffer containing 136 mM NaI, 3 mM KNO3, 2 mM Ca(NO3)2, 11 mM glucose, and 20 mM HEPES, adjusted to pH 7.4 with NaOH. Cells were thoroughly washed with efflux buffer (136 mM NaNO3 replacing NaI in the loading buffer) to remove extracellular iodide and then equilibrated in 2.5 ml of efflux buffer for 1 min. The efflux buffer was changed at 1-min intervals. Four minutes after anion substitution, cells were exposed to 10 µM forskolin and 50 µM genistein for 4 min. The amount of iodide in each 2.5-ml sample of efflux buffer was determined using an iodideselective electrode (Mettler Toledo, Columbus, OH). Cell loading and measurements were performed at room temperature.
|
| Results |
|---|
|
|
|---|
Isc = 61 ± 7.3 µA/cm2; n = 6) and nasal (
Isc = 151 ± 17.3 µA/cm2; n = 6) native epithelia. We also examined possible effects of the P. acidus extract on other purinergic receptors. Stimulation of luminal P2Y2 receptors with ATP or UTP (both 100 µM), or inhibition of P2Y receptors with pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid or suramin (both 100 µM) did not interfere with the ability of P. acidus to induce Cl- secretion. Moreover, a role of P2Y1 receptors in the effects of P. acidus on epithelial transport was unlikely, because P. acidus had similar effects in the presence of the specific P2Y1 agonist MRS2179 (10 µM) (data not shown). Taken together, our data indicate that activation of A1 and A2B receptors contributes substantially to the observed induction of Cl- secretion by P. acidus extract.
Activation of Ca2+ and cAMP-dependent Cl- Secretion by P. acidus in Mouse Trachea. Luminal stimulation of mouse and human airways with adenosine increases intracellular cAMP and leads to a steady CFTR-dependent Cl- secretion (Huang et al., 2001
). We found that the transient Isc and a substantial part of the steady state Isc activated by adenosine (100 µM) in mouse airways is inhibited by niflumic acid (NFA, 10 µM), an inhibitor of Ca2+ activated Cl- channels (Fig. 2, A and B). Thus, adenosine activates both cAMP- and Ca2+-dependent Cl- secretion. Similar to adenosine, both transient and steady secretion induced by P. acidus were inhibited by NFA and DIDS, another blocker of Ca2+-activated Cl- channels (Fig. 2, C and D). We further examined whether P. acidus also activates cAMP-dependent CFTR Cl- channels. To that end, we prestimulated mouse airways with IBMX (100 µM) and forskolin (2 µM) and found that Cl- secretion induced by P. acidus was significantly reduced. Moreover, application of the CFTR inhibitor glibenclamide also reduced steady-state Isc induced by P. acidus (Fig. 2F). Thus, P. acidus activates two luminal Cl- channels, CFTR and a Ca2+-activated Cl- channel of unknown molecular identity. The effects of P. acidus were not limited to mouse trachea; it also activated Isc of 161 ± 17.5 µA/cm2 (n = 6) and 48 ± 8.7 µA/cm2 (n = 6) when applied to mouse nasal epithelium and proximal colon, respectively.
|
Activation of Cl- Secretion by Kaempferol and DHBA. P. acidus extract contains the flavonoid kaempferol and DHBA (Li and Wang, 2004
) (Fig. 4). Both compounds induced a dose-dependent Cl- secretion, albeit smaller than that activated by adenosine (Fig. 4). Substantial amounts of the Cl- secretion induced by kaempferol and DHBA were inhibited by the Cl- channel blocker NFA. We then sought to determine whether the effects of P. acidus extract on epithelial ion transport could be reproduced by a mixture of the isolated components adenosine, kaempferol, and DHBA. As shown in Fig. 5, the mixture demonstrated similar, albeit larger effects than those produced by the P. acidus extract. Thus, a defined mixture of isolated components reproduces the effects of P. acidus.
|
|
|
P. acidus also induced Cl- secretion in overexpressing cells. Oocytes from X. laevis endogenously express Ca2+-activated Cl- channels. As shown in Fig. 7A, P. acidus (100 µg/ml) induced a transient Cl- secretion, probably due to the activation of endogenous Ca2+-activated Cl- channels in X. laevis oocytes. DIDS (100 µM) completely suppressed current activation by P. acidus (Fig. 7, A and B). In contrast to noninjected oocytes, where P. acidus only transiently activated Cl- secretion, oocytes overexpressing wild-type (wt) CFTR exhibited both transient and steady-state Cl- currents when exposed to P. acidus (Fig. 7C). Current activation was significant compared with the effects of the phosphodiesterase inhibitor IBMX (1 mM), which increases intracellular cAMP (Fig. 7, C and D). Thus, in X. laevis oocytes, P. acidus activates endogenous Ca2+-activated Cl- channels and overexpressed CFTR Cl- channels. Numerous reports have demonstrated inhibition of ENaC during activation of CFTR. In fact, lack of ENaC inhibition by mutant CFTR has been proposed as a mechanism for enhanced Na+ absorption in CF (Stutts et al., 1995
). We thus coexpressed CFTR and the epithelial Na+ channel ENaC in X. laevis oocytes and found amiloride-sensitive Na+ currents under control conditions (Fig. 7E). Activation of Ca2+-dependent and CFTR Cl- currents by P. acidus (100 µg/ml) inhibited amiloride-sensitive Na+ channels (Fig. 7, E and F). Moreover, inhibition of ENaC was not observed by P. acidus when CFTR was inhibited by the specific inhibitor 172, thus showing that ENaC currents were not directly inhibited by P. acidus. In other words, P. acidus had no direct effect on Na+ currents in the absence of CFTR activity.
|
P. acidus Is Not Toxic for Mammalian Cells and Acts As a Potentiator of CFTR. Using a viability/cytotoxicity test (see Materials and Methods) we examined whether P. acidus exerts any toxic effect on mammalian cells (Fig. 8). After 48-h incubation with P. acidus in the 50-200 µg/ml concentration range, BHK cells stably expressing wt-CFTR or Phe508del-CFTR were analyzed by flow cytometry. Graphs represent bivariate frequency distributions of red-fluorescent (585 nm) ethidium homodimer-1-stained dead cell population (y-axis, arbitrary units) over green-fluorescent (530 nm) calcein-stained live cell population (x-axis, arbitrary units). The fraction of live cells was larger than 95% under all conditions, indicating that P. acidus is not toxic for mammalian cells, up to a concentration of 200 µg/ml (Fig. 8, A and B). The cells continued to divide normally in the presence of the extract (data not shown).
|
|
|
| Discussion |
|---|
|
|
|---|
Phytoflavonoids such as genistein have been extensively tested and have been proven to activate CFTR (Hwang et al., 1997
; Illek and Fischer, 1998
; Mall et al., 2000
; Suaud et al., 2001
, 2002
). Flavonoids also restore functional interactions between mutant Phe508del-CFTR or G551-CFTR and ENaC (Suaud et al., 2001
). Genistein is currently under investigation in a phase I pilot study in coadministration with phenylbutyrate. Also other dietary flavonols, such as quercetin and kaempferol, have been identified as activators of Cl- secretion (Cermak et al., 1998
). The effects of the spice curcumin have been inconsistent among different groups who tested this compound, but are nevertheless currently under examination in a phase I clinical trial (Berger et al., 2004
; Egan et al., 2004
; Song et al., 2004
). Another study has demonstrated opening of CFTR Cl- channels by vitamin C (L-ascorbate) (Fischer et al., 2004
). Vitamin C was identified as a biological regulator of CFTR-mediated Cl- secretion. Although citrus limonoids were found to increase Cl- conductance in epithelial cells to an extent comparable with that of genistein (deCarvalho et al., 2002
), we were unable to detect significant effects of L-ascorbate in mouse trachea (data not shown). This is probably due to the relatively low levels of CFTR expression in this tissue.
Constituents of the Herbal Plant P. acidus Enhance Electrolyte Secretion. Plant extracts from P. acidus contain various bioactive compounds, such as adenosine, kaempferol, and hypogallic acid. The effects of these compounds include: 1) increasing the intracellular second messengers cAMP and Ca2+ and thereby activating CFTR- and Ca2+-dependent Cl- channels; 2) activating CFTR directly, as demonstrated for flavonoids; 3) increasing membrane expression of CFTR; 4) enhancing the driving force for luminal Cl- exit by activating basolateral K+ channels; and 5) reducing ENaC activity through activation of CFTR, thereby reducing NaCl absorption and preventing dehydration of the airway surface liquid (Fig. 10).
The components of P. acidus have been shown to affect membrane ion transport in previous studies. Apart from activating CFTR directly, flavonoids have also been shown to inhibit endoplasmic reticulum Ca2+-ATPase and to stimulate mitochondrial Ca2+ uptake (Montero et al., 2004
), which may affect endoplasmic reticulum chaperones and thus CFTR membrane traffic. Flavonoids also lead to a favorable redistribution of Phe508del-CFTR within cellular compartments, without directly affecting processing of the protein (Lim et al., 2004
). This may explain why P. acidus had only modest effects on biogenesis of CFTR, but activated Phe508del-CFTR currents after incubation of oocytes or short-term application to Phe508del-CFTR-expressing BHK cells. Adenosine and other xanthines have been found to bind and activate mutant and wt-CFTR directly. Moreover, adenosine activates purinergic A1 and A2B receptors, thereby increasing intracellular Ca2+ and cAMP. Hypogallic acid induced Ca2+-dependent Cl- secretion, an effect that had been demonstrated for caffeic acid, another component of P. acidus (Lin et al., 2004
).
Previous studies demonstrated that the P2Y receptor agonist ATP had only short-term effects on ion transport in the airways, due to inactivation by rapid hydrolysis. It is unlikely that the effects of P. acidus are short lasting, because its components are more stable and will probably not be removed from the airway surface as effectively. Subsequent studies in a mouse model will have to compare the effects of local versus systemic application. These studies should also examine pharmacokinetics of absorption and pharmacodynamics of these compounds, which are currently not known.
EthnopharmacologyA New Source for CF Therapeutics? The present study identified bioactive components in herbal extracts of P. acidus. In a recent elegant study, a growth-deficient yeast strain was used as a drug discovery surrogate bioassay to identify natural plant products restoring Cl- channel function (deCarvalho et al., 2002
). During the course of this study, limonoids were identified as Phe508del-CFTR correctors. In previous studies with the extract from another medicinal plant, Randia siamensis, we also found effects on ion transport properties in mouse trachea (Jansakul et al., 1999
). Extracts from R. siamensis induced Cl- secretion by activation of Ca2+-dependent Cl- channels. Similar to P. acidus, R. siamensis also contains flavonoids and other bioactive compounds, such as pseudoginsenosides. Ginsenosides and pseudoginsenosides are active ingredients of the ginseng root (Blumenthal, 2001
) that have been shown to stimulate Ca2+-activated Cl- channels by activation of phospholipase C and mobilization of intracellular Ca2+ (Choi et al., 2001
). Moreover, ginsenoside Re has been shown to increase NO, which activates K+ and Ca2+ channels as well as Cl- secretion via wt-CFTR and mutant Phe508del-CFTR (Dong et al., 1995
; Kamosinska et al., 1997
; Bai et al., 2004
; Lee et al., 2004
). Taken together, the use of natural plant products provides new avenues for the treatment of CF. P. acidus extract can thus be used to enhance the activity of CFTR mutants with residual function or, in combination with compounds that rescue mutants with traffic defects such as Phe508del-CFTR, to further stimulate the Cl- channel activity of these mutants.
| Acknowledgements |
|---|
| Footnotes |
|---|
R.S. and K.K. share senior authorship. M.S. and J.O. contributed equally to the present work.
ABBREVIATIONS: CF, cystic fibrosis; CFTR, cystic fibrosis transmembrane conductance regulator; ENaC, epithelial Na+ channels; 8-SPT, 8-sulfophenyltheophylline; DPC-PX, 1,3-dipropyl-8-cyclopentylxanthine; DMEM, Dulbecco's modified Eagle's medium; DHBA, 2,3-dihydroxybenzoic acid (hypogallic acid); Vte, transepithelial voltage; Rte, transepithelial resistance; Isc, short-circuit current; BHK, baby hamster kidney; wt, wild-type; IBMX, 3-isobutyl-1-methylxanthine; DIDS, 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid; CPA, cyclopiazonic acid; MRS2179, 2'-deoxy-N6-methyl adenosine 3',5'-diphosphate; U73122
[GenBank]
, 1-[6-((17
-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl]-1H-pyrrole-2,5-dione; NFA, niflumic acid; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; AM, acetoxymethyl ester; CCH, carbachol.
Address correspondence to: Prof. Dr. Karl Kunzelmann, Institut für Physiologie, Universität Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany. E-mail: uqkkunze{at}mailbox.uq.edu.au
| References |
|---|
|
|
|---|
Berger AL, Randak CO, Ostedgaard LS, Karp PH, Vermeer DW, and Welsh MJ (2004) Curcumin stimulates CFTR Cl- channel activity. J Biol Chem 280: 5221-5226.
Bjarnsholt T, Jensen PO, Rasmussen TB, Christophersen L, Calum H, Hentzer M, Hougen HP, Rygaard J, Moser C, Eberl L, et al. (2005) Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology 151: 3873-3880.
Blumenthal M (2001) Asian ginseng: potential therapeutic uses. Adv Nurse Pract 9: 26-28.[Medline]
Bobadilla JL, Macek M Jr, Fine JP, and Farrell PM (2002) Cystic fibrosis: a world-wide analysis of CFTR mutations correlation with incidence data and application to screening. Hum Mutat 19: 575-606.[CrossRef][Medline]
Boucher RC (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23: 146-158.
Cermak R, Follmer U, and Wolffram S (1998) Dietary flavonol quercetin induces chloride secretion in rat colon. Am J Physiol 275: G1166-G1172.
Choi S, Rho SH, Jung SY, Kim SC, Park CS, and Nah SY (2001) A novel activation of Ca2+-activated Cl- channel in Xenopus oocytes by ginseng saponins: evidence for the involvement of phospholipase C and intracellular Ca2+ mobilization. Br J Pharmacol 132: 641-648.[CrossRef][Medline]
Clancy JP, Ruiz FE, and Sorscher EJ (1999) Adenosine and its nucleotides activate wild-type and R117H CFTR through an A2B receptor-coupled pathway. Am J Physiol 276: C361-C369.
Cohen BE, Lee G, Jacobson KA, Kim YC, Huang Z, Sorscher EJ, and Pollard HB (1997) 8-Cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and deltaf508 mutant first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator. Biochemistry 36: 6455-6461.[CrossRef][Medline]
deCarvalho AV, Ndi CP, Tsopmo A, Tane P, Ayafor J, Connolly JD, and Teem JL (2002) A novel natural product compound enhances camp-regulated chloride conductance of cells expressing CFTR-f508del. Mol Med 8: 75-87.[Medline]
Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, and Welsh MJ (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature (Lond) 358: 761-764.[CrossRef][Medline]
Dong YJ, Chao AC, Kouyama K, Hsu YP, Bocian RC, Moss RB, and Gardner P (1995) Activation of CFTR chloride current by nitric oxide in human T lymphocytes. EMBO (Eur Mol Biol Organ) J 14: 2700-2707.[Medline]
Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J, Canny S, Du K, Lukacs GL, and Caplan MJ (2004) Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science (Wash DC) 304: 600-602.
Farinha CM and Amaral MD (2005) Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin. Mol Cell Biol 25: 5242-5252.
Fischer H, Schwarzer C, and Illek B (2004) Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci USA 101: 3691-3696.
Huang P, Lazarowski ER, Tarran R, Milgram SL, Boucher RC, and Stutts MJ (2001) Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells. Proc Nat Acad Sci USA 98: 14120-14125.
Hwang T-C, Wang F, Yang IC, and Reenstra WW (1997) Genistein potentiates wild-type and delta F508-CFTR channel activity. Am J Physiol 273: C988-C998.
Illek B and Fischer H (1998) Flavonoids stimulate Cl- conductance of human airway epithelium in vitro and in vivo. Am J Physiol 275: L902-L910.
Jansakul C, Intarit K, Itharat A, Phadungcharoen T, Ruangrungsi N, Merica A, and Lange GL (1999) Biological activity of crude extract and saponin pseudoginsenoside-RT1 derived from the fruit of Randia siamensis. Pharmaceutical Biology 37: 42-45.
Kamosinska B, RADOMSKI MW, Duszyk M, Radomski A, and Man SF (1997) Nitric oxide activates chloride currents in human lung epithelial cells. Am J Physiol 272: L1098-L1104.
Kanchanapoom T, Kasai R, and Yamasaki K (2001) Acetylated triterpene saponins from the Thai medicinal plant, Sapindus emarginatus. Chem Pharm Bull (Tokyo) 49: 1195-1197.
Kerem E (2005) Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy. Pediatr Pulmonol 40: 183-196.[CrossRef][Medline]
Kunzelmann K and Mall M (2003) Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics. Am J Respir Med 2: 299-309.[Medline]
Lee BH, Jeong SM, Ha TS, Park CS, Lee JH, Kim JH, Kim DH, Han JS, Kim HC, Ko SR, et al. (2004) Ginsenosides regulate ligand-gated ion channels from the outside. Mol Cells 18: 115-121.[Medline]
Li H and Wang Q (2004) Evaluation of free hydroxyl radical scavenging activities of some Chinese herbs by capillary zone electrophoresis with amperometric detection. Anal Bioanal Chem 378: 1801-1805.[CrossRef][Medline]
Lim M, McKenzie K, Floyd AD, Kwon E, and Zeitlin PL (2004) Modulation of DeltaF508 CFTR trafficking and function with 4-PBA and flavonoids. Am J Respir Cell Mol Biol 31: 351-357.
Lin MW, Yang SR, Huang MH, and Wu SN (2004) Stimulatory actions of caffeic acid phenethyl ester, a known inhibitor of NF-
B activation, on Ca2+-activated K+ current in pituitary GH3 cells. J Biol Chem 279: 26885-26892.
Ma T, Vetrivel L, Yang H, Pedemonte N, Zegarra-Moran O, Galietta LJ, and Verkman AS (2002) High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening. J Biol Chem 277: 37235-37241.
Mall M, Wissner A, Hübner M, Kühr J, Brandis M, Greger R, and Kunzelmann K (2000) Effect of genistein on native epithelial tissues from normal individuals and CF patients and on CFTR expressed in Xenopus oocytes. Br J Pharmacol 130: 1884-1892.[CrossRef][Medline]
Montero M, Lobaton CD, Hernandez-Sanmiguel E, Santodomingo J, Vay L, Moreno A, and Alvarez J (2004) Direct activation of the mitochondrial calcium uniporter by natural plant flavonoids. Biochem J 384: 19-24.[CrossRef][Medline]
Moran O and Zegarra-Moran O (2005) A quantitative description of the activation and inhibition of CFTR by potentiators: genistein. FEBS Lett 579: 3979-3983.[CrossRef][Medline]
Mueller-Oerlinghausen B, Ngamwathana W, and Kanchanapee P (1971) Investigation into Thai medicinal plants said to cure diabetes. J Med Assoc Thai 54: 105-112.[Medline]
Panthong A, Kanjanapothi D, and Taylor WC (1986) Ethnobotanical review of medicinal plants from Thai traditional books, part I: plants with anti-inflammatory, anti-asthmatic and antihypertensive properties. J Ethnopharmacol 18: 213-228.[CrossRef][Medline]
Pedemonte N, Lukacs GL, Du K, Caci E, Zegarra-Moran O, Galietta LJ, and Verkman AS (2005) Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Investig 115: 2564-2571.[CrossRef][Medline]
Song Y, Sonawane ND, Salinas D, Qian L, Pedemonte N, Galietta LJ, and Verkman AS (2004) Evidence against rescue of defective
F508-CFTR cellular processing by curcumin in cell culture and mouse models. J Biol Chem 279: 40629-40633.
Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, and Boucher RC (1995) CFTR as a cAMP-dependent regulator of sodium channels. Science (Wash DC) 269: 847-850.
Suaud L, Carattino M, Kleyman TR, and Rubenstein RC (2002) Genistein improves regulatory interactions between G551D-cystic fibrosis transmembrane conductance regulator and the epithelial sodium channel in Xenopus oocytes. J Biol Chem 277: 50341-50347.
Suaud L, Li J, Jiang Q, Rubenstein RC, and Kleyman TR (2001) Genistein restores functional interactions between F508del-CFTR and ENaC in Xenopus oocytes. J Biol Chem 277: 8928-8933.
Van Goor F, Straley KS, Cao D, Gonzalez J, Hadida S, Hazlewood A, Joubran J, Knapp T, Makings LR, Miller M, et al. (1996) RESCUE OF F508del-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am J Physiol 290: L1117-L1130.
Wolfender JL, Ndjoko K, and Hostettmann K (2001) The potential of LC-NMR in phytochemical analysis. Phytochem Anal 12: 2-22.[CrossRef][Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||